404 related articles for article (PubMed ID: 33418900)
1. Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide?
Iftikhar A; Islam M; Shepherd S; Jones S; Ellis I
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33418900
[TBL] [Abstract][Full Text] [Related]
2. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress.
Meaney MJ; Diorio J; Francis D; Widdowson J; LaPlante P; Caldji C; Sharma S; Seckl JR; Plotsky PM
Dev Neurosci; 1996; 18(1-2):49-72. PubMed ID: 8840086
[TBL] [Abstract][Full Text] [Related]
3. The effects of suppressing the biological stress systems on social threat-assessment following acute stress.
Ali N; Cooperman C; Nitschke JP; Baldwin MW; Pruessner JC
Psychopharmacology (Berl); 2020 Oct; 237(10):3047-3056. PubMed ID: 32601985
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke.
Mracsko E; Liesz A; Karcher S; Zorn M; Bari F; Veltkamp R
Brain Behav Immun; 2014 Oct; 41():200-9. PubMed ID: 24886966
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine aspects of the response to stress.
Miller DB; O'Callaghan JP
Metabolism; 2002 Jun; 51(6 Suppl 1):5-10. PubMed ID: 12040534
[TBL] [Abstract][Full Text] [Related]
7. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
8. Oral health-related quality of life, oral aesthetics and oral function in head and neck cancer patients after oral rehabilitation.
Fromm L; Gotfredsen K; Wessel I; Øzhayat EB
J Oral Rehabil; 2019 Aug; 46(8):738-746. PubMed ID: 31013356
[TBL] [Abstract][Full Text] [Related]
9. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases.
Lorton D; Lubahn C; Bellinger DL
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):1-30. PubMed ID: 14561173
[TBL] [Abstract][Full Text] [Related]
10. Chronic Stress Promotes Cancer Development.
Dai S; Mo Y; Wang Y; Xiang B; Liao Q; Zhou M; Li X; Li Y; Xiong W; Li G; Guo C; Zeng Z
Front Oncol; 2020; 10():1492. PubMed ID: 32974180
[TBL] [Abstract][Full Text] [Related]
11. A preliminary study on the relationships between global health/quality of life and specific head and neck cancer quality of life domains in Puerto Rico.
Psoter WJ; Aguilar ML; Levy A; Baek LS; Morse DE
J Prosthodont; 2012 Aug; 21(6):460-71. PubMed ID: 22469330
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: sex differences in regulation of stress responsivity.
Oyola MG; Handa RJ
Stress; 2017 Sep; 20(5):476-494. PubMed ID: 28859530
[TBL] [Abstract][Full Text] [Related]
13. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
14. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
[TBL] [Abstract][Full Text] [Related]
16. What is behind the lifestyle risk factors for head and neck cancer?
Iftikhar A; Islam M; Shepherd S; Jones S; Ellis I
Front Psychol; 2022; 13():960638. PubMed ID: 36312160
[TBL] [Abstract][Full Text] [Related]
17. The value of quality-of-life questionnaires in head and neck cancer.
Verdonck-de Leeuw IM; van Nieuwenhuizen A; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):142-7. PubMed ID: 22249168
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.
Perry A; Lee SH; Cotton S; Kennedy C
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011112. PubMed ID: 27562477
[TBL] [Abstract][Full Text] [Related]
19. Recovering function and surviving treatments are primary motivators for health behavior change in patients with head and neck cancer: Qualitative focus group study.
Henry M; Bdira A; Cherba M; Lambert S; Carnevale FA; MacDonald C; Hier M; Zeitouni A; Kost K; Mlynarek A; Black M; Rosberger Z; Frenkiel S
Palliat Support Care; 2016 Aug; 14(4):364-75. PubMed ID: 26592923
[TBL] [Abstract][Full Text] [Related]
20. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
